United States set
language
Menu Shopping cart $0 Search
Manufactured by BioVendor

sCD40L Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Other names:CD40-L, CD40 ligand, Tumor necrosis factor ligand superfamily member 5, TNF related activation protein, T cell antigen Gp39, CD154 antigen
  • Species:Human
United States orders are shipped from our US branch, BioVendor, LLC
Cat. No. Size Price


RAF093R 96 wells (1 kit) $808
PubMed Product Details
Technical Data

Type

Sandwich ELISA, HRP-labelled antibody

Applications

Serum, Plasma, Cell culture supernatant

Sample Requirements

20 µl/well

Shipping

At ambient temperature. Upon receipt, store the product at the temperature recommended below.

Calibration Curve

Calibration Range

0.16–10 ng/ml

Limit of Detection

0.06 ng/ml

Intra-assay (Within-Run)

CV = 4.0%

Inter-assay (Run-to-Run)

CV = 6.8%

Spiking Recovery

91,00%

Dilution Linearity

105,00%

Summary

Research topic

Apoptosis, Cardiovascular disease, Cell surface proteins (sCD), Cytokines and chemokines and related molecules, Transplantation

Summary

CD40 belongs to the TNF receptor superfamily. A key role of CD40/CD40ligand interactions in immune activation, particularly in T-cell dependent B cell responses is anticipated. This molecule as well as the other ligands of the family share the property of co-stimulation of T-cell proliferation and are all expressed by activated T-cells.Because the ligand of CD40 (CD40L) is expressed on activated T helper cells, B cells may escape from apoptosis and are activated when the immune system interacts with foreign antigens, which are normally able to activate T-helper cells. Thus the CD40/CD40L interaction plays a central role in the various phases of the B cell response to T-dependent antigens.

Product References (10)

References

  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
Related Products Docs
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít